See more : First Guaranty Bancshares, Inc. (FGBI) Income Statement Analysis – Financial Results
Complete financial analysis of U.S. Physical Therapy, Inc. (USPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of U.S. Physical Therapy, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Shanghai Electric Group Company Limited (SIELF) Income Statement Analysis – Financial Results
- Capacit’e Infraprojects Limited (CAPACITE.NS) Income Statement Analysis – Financial Results
- China Energy Development Holdings Limited (0228.HK) Income Statement Analysis – Financial Results
- DUET Acquisition Corp. (DUET) Income Statement Analysis – Financial Results
- Siglent Technologies CO., Ltd. (688112.SS) Income Statement Analysis – Financial Results
U.S. Physical Therapy, Inc. (USPH)
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 604.80M | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M | 414.05M | 356.55M | 331.30M | 305.07M | 264.06M | 252.09M | 237.01M | 211.23M | 201.41M | 187.69M | 151.69M | 135.19M | 132.12M | 118.31M | 105.57M | 94.74M | 80.95M | 63.22M | 49.94M | 44.00M | 38.80M | 32.20M | 24.90M | 17.20M | 8.40M | 2.40M | 600.00K |
| Cost of Revenue | 492.82M | 441.12M | 377.84M | 328.52M | 369.50M | 352.25M | 323.43M | 274.53M | 252.94M | 228.91M | 199.36M | 189.50M | 172.51M | 151.82M | 146.24M | 140.08M | 114.33M | 99.35M | 96.21M | 85.28M | 74.60M | 64.53M | 54.88M | 42.90M | 34.09M | 30.80M | 27.30M | 22.10M | 17.40M | 13.20M | 6.20M | 1.70M | 500.00K |
| Gross Profit | 111.99M | 112.02M | 117.18M | 94.45M | 112.47M | 101.66M | 90.62M | 82.01M | 78.36M | 76.17M | 64.70M | 62.59M | 64.49M | 59.42M | 55.17M | 47.60M | 37.36M | 35.84M | 35.91M | 33.03M | 30.96M | 30.21M | 26.07M | 20.32M | 15.84M | 13.20M | 11.50M | 10.10M | 7.50M | 4.00M | 2.20M | 700.00K | 100.00K |
| Gross Profit Ratio | 18.52% | 20.25% | 23.67% | 22.33% | 23.34% | 22.40% | 21.89% | 23.00% | 23.65% | 24.97% | 24.50% | 24.83% | 27.21% | 28.13% | 27.39% | 25.36% | 24.63% | 26.51% | 27.18% | 27.92% | 29.33% | 31.89% | 32.20% | 32.14% | 31.73% | 30.00% | 29.64% | 31.37% | 30.12% | 23.26% | 26.19% | 29.17% | 16.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 51.95M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -9.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.43M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 4.20M | 4.50M | 3.50M | 1.70M | 400.00K |
| Other Expenses | 0.00 | 859.00K | -4.60M | -13.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.79M | 3.24M | 3.35M | 0.00 | 0.00 | 0.00 | 604.00K | 238.00K | 0.00 | 0.00 | 0.00 | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| Operating Expenses | 42.43M | 46.11M | 41.94M | 28.54M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 28.56M | 26.23M | 26.74M | 23.73M | 17.33M | 17.25M | 17.03M | 17.04M | 13.97M | 11.33M | 9.12M | 9.94M | 8.58M | 7.70M | 6.70M | 6.50M | 5.90M | 5.80M | 4.10M | 1.90M | 400.00K |
| Cost & Expenses | 535.25M | 487.23M | 419.78M | 357.06M | 414.54M | 393.60M | 359.32M | 307.01M | 284.01M | 259.31M | 225.29M | 214.29M | 201.08M | 178.04M | 172.98M | 163.81M | 131.65M | 116.60M | 113.24M | 102.32M | 88.57M | 75.87M | 64.00M | 52.84M | 42.67M | 38.50M | 34.00M | 28.60M | 23.30M | 19.00M | 10.30M | 3.60M | 900.00K |
| Interest Income | 3.77M | 859.00K | 199.00K | 142.00K | 46.00K | 93.00K | 88.00K | 93.00K | 81.00K | 18.00K | 7.00K | 6.00K | 5.45M | 586.00K | 8.00K | 260.00K | 273.00K | 332.00K | 361.00K | 146.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.30M | 5.78M | 942.00K | 1.63M | 2.08M | 2.04M | 21.06M | 11.48M | 1.03M | 1.09M | 538.00K | 557.00K | 496.00K | 236.00K | 352.00K | 542.00K | 301.00K | 0.00 | 361.00K | 0.00 | 189.00K | 214.00K | 266.00K | 780.00K | 727.00K | 700.00K | 0.00 | 700.00K | 700.00K | 600.00K | 200.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 15.70M | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M | 9.71M | 8.78M | 7.95M | 6.74M | 5.56M | 5.29M | 5.45M | 5.67M | 5.90M | 5.97M | 4.99M | 4.49M | 4.31M | 4.32M | 3.59M | 2.96M | 2.57M | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| EBITDA | 74.37M | 76.09M | 85.73M | 77.68M | 83.08M | 72.01M | 64.53M | 58.41M | 55.33M | 52.53M | 44.34M | 43.10M | 46.83M | 39.44M | 34.16M | 30.10M | 25.02M | 23.09M | 24.84M | 20.83M | 20.59M | 21.83M | 19.51M | 12.72M | 9.36M | 7.60M | 6.70M | 5.30M | 3.30M | -500.00K | -1.30M | -1.00M | -300.00K |
| EBITDA Ratio | 12.30% | 14.95% | 17.85% | 18.11% | 17.24% | 15.46% | 15.58% | 16.38% | 16.70% | 17.22% | 16.79% | 17.10% | 19.76% | 18.67% | 17.05% | 15.90% | 16.50% | 17.08% | 18.01% | 17.37% | 19.50% | 23.04% | 24.11% | 20.11% | 18.74% | 17.73% | 17.27% | 16.46% | 12.05% | -2.91% | -15.48% | -41.67% | -50.00% |
| Operating Income | 69.56M | 56.80M | 76.77M | 52.41M | 67.43M | 60.31M | 54.73M | 49.53M | 47.29M | 45.77M | 38.77M | 37.80M | 35.93M | 33.19M | 28.43M | 23.88M | 20.04M | 18.60M | 18.88M | 15.99M | 17.00M | 18.87M | 16.95M | 10.38M | 7.27M | 5.50M | 4.80M | 3.60M | 1.60M | -1.80M | -1.90M | -1.20M | -300.00K |
| Operating Income Ratio | 11.50% | 10.27% | 15.51% | 12.39% | 13.99% | 13.29% | 13.22% | 13.89% | 14.28% | 15.00% | 14.68% | 15.00% | 15.16% | 15.71% | 14.11% | 12.72% | 13.21% | 13.76% | 14.29% | 13.52% | 16.10% | 19.92% | 20.94% | 16.42% | 14.55% | 12.50% | 12.37% | 11.18% | 6.43% | -10.47% | -22.62% | -50.00% | -50.00% |
| Total Other Income/Expenses | -20.18M | -1.23M | 2.55M | 13.10M | 3.48M | -103.00K | -20.97M | -11.39M | -7.16M | -1.07M | -531.00K | 52.00K | 446.00K | 350.00K | -344.00K | -282.00K | -5.76M | -5.35M | -5.61M | -366.00K | -5.16M | -5.06M | -5.45M | -4.25M | -3.30M | -2.80M | -2.30M | -1.90M | 300.00K | 0.00 | 0.00 | 0.00 | 300.00K |
| Income Before Tax | 49.38M | 55.57M | 73.20M | 65.51M | 70.91M | 60.21M | 33.76M | 38.15M | 46.34M | 44.70M | 38.24M | 37.25M | 40.88M | 33.54M | 28.08M | 16.51M | 14.28M | 13.25M | 14.30M | 10.78M | 11.78M | 13.72M | 11.50M | 6.14M | 3.96M | 2.70M | 2.50M | 1.70M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 8.16% | 10.05% | 14.79% | 15.49% | 14.71% | 13.26% | 8.15% | 10.70% | 13.99% | 14.65% | 14.48% | 14.78% | 17.25% | 15.88% | 13.94% | 8.80% | 9.41% | 9.80% | 10.82% | 9.11% | 11.16% | 14.49% | 14.21% | 9.71% | 7.93% | 6.14% | 6.44% | 5.28% | 7.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 12.16M | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M | 6.03M | 11.88M | 14.65M | 14.27M | 12.24M | 11.03M | 11.10M | 8.84M | 8.11M | 6.51M | 5.47M | 5.06M | 5.51M | 4.10M | 4.45M | 5.24M | 4.43M | 2.40M | 1.57M | 1.10M | 100.00K | 100.00K | 900.00K | 1.00M | 300.00K | 0.00 | 200.00K |
| Net Income | 14.67M | 43.41M | 57.92M | 52.49M | 57.26M | 10.10M | 22.26M | 20.55M | 22.28M | 19.77M | 12.72M | 17.93M | 20.97M | 15.65M | 11.77M | 10.00M | 8.89M | 6.30M | 8.79M | 6.68M | 7.33M | 8.49M | 7.07M | 3.74M | 2.39M | 1.60M | 2.40M | 1.60M | 700.00K | -2.80M | -2.20M | -1.20M | -200.00K |
| Net Income Ratio | 2.43% | 7.85% | 11.70% | 12.41% | 11.88% | 2.23% | 5.38% | 5.76% | 6.72% | 6.48% | 4.82% | 7.11% | 8.85% | 7.41% | 5.84% | 5.33% | 5.86% | 4.66% | 6.65% | 5.64% | 6.94% | 8.96% | 8.74% | 5.91% | 4.79% | 3.64% | 6.19% | 4.97% | 2.81% | -16.28% | -26.19% | -50.00% | -33.33% |
| EPS | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.52 | 1.78 | 1.34 | 1.01 | 0.84 | 0.75 | 0.54 | 0.74 | 0.56 | 0.66 | 0.77 | 0.70 | 0.13 | 0.12 | 0.05 | 0.08 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| EPS Diluted | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.51 | 1.75 | 1.32 | 1.00 | 0.83 | 0.75 | 0.54 | 0.73 | 0.54 | 0.61 | 0.67 | 0.55 | 0.11 | 0.11 | 0.05 | 0.07 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| Weighted Avg Shares Out | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.06M | 11.80M | 11.81M | 11.64M | 11.70M | 11.91M | 11.64M | 11.69M | 11.92M | 11.93M | 11.11M | 11.02M | 10.10M | 9.56M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
| Weighted Avg Shares Out (Dil) | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.08M | 11.90M | 11.98M | 11.87M | 11.81M | 12.06M | 11.72M | 11.69M | 12.04M | 12.37M | 12.02M | 12.67M | 12.86M | 10.70M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
U.S. Physical Therapy Announces the Acquisition of an Eight-Clinic Hand and Physical Therapy Practice
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a hand and physical therapy practice with eight clinic locations in Wyoming...
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right...
U.S. Physical Therapy, Inc. (USPH) Q3 2024 Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q3 2024 Earnings Conference Call November 6, 2024 10:30 AM ET Company Participants Chris Reading - Chairman and CEO Carey Hendrickson - Chief Financial Officer Eric Williams - President and COO Graham Reeve -...
U.S. Physical Therapy (USPH) Q3 Earnings and Revenues Top Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.62 per share a year ago.
U.S. Physical Therapy (USPH) Reports Next Week: Wall Street Expects Earnings Growth
U.S. Physical Therapy (USPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
U.S. Physical Therapy, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and nine months ended September 30, 2024,...
U.S. Physical Therapy Announces Acquisition of 50-Clinic Physical Therapy Management Services Organization
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH") (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that it has signed an agreement to purchase a 50% equity interest in a management...
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their...
$1.5M Bet On Elastic? Check Out These 4 Stocks Executives Are Buying
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.73 per share, missing the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.76 per share a year ago.
Source: https://incomestatements.info
Category: Stock Reports